Methylamine

Methylamine

SCHEMBL3227067

CN.NC(=O)c1cc(C(F)(F)F)ccc1C(F)(F)F

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.68
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CFTR P13569 1/20 0.45
CASP1 P29466 1/20 0.43
JAK2 O60674 1/20 0.43
KMT2A Q03164 1/20 0.42
PSMB11 A5LHX3 2/20 0.41
PSMA7 O14818 2/20 0.41
PSMB1 P20618 2/20 0.41
PSMA1 P25786 2/20 0.41
PSMA2 P25787 2/20 0.41
PSMA3 P25788 2/20 0.41
PSMA4 P25789 2/20 0.41
PSMB8 P28062 2/20 0.41
PSMB9 P28065 2/20 0.41
PSMA5 P28066 2/20 0.41
PSMB4 P28070 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2856986 0.96 CES2 (0.72) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8608698 0.88 CES2 (0.56) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL31004884 0.81 CES2 (0.72) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL2001145 0.81 CES2 (0.72) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL1002163 0.81 CES2 (0.72) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30738533 0.81 CES2 (0.49) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5323409 0.80 CES2 (0.50) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL12095449 0.80 CES2 (0.55) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL16404629 0.80 CES2 (0.46) CES2ALDH1A1CYP3A4TMPRSS4PARP1
SCHEMBL26020665 0.80 CES2 (0.70) CES2KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010020548-A1 GLYT1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-02-25 WO disclosed